日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer

一项针对晚期难治性乳腺癌患者的Denileukin Diftitox II期研究

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13020117
Gwin, William R 3rd; Salazar, Lupe G; Dai, James Y; Higgins, Doreen; Coveler, Andrew L; Childs, Jennifer S; Blancas, Rosie; Dang, Yushe; Reichow, Jessica; Slota, Meredith; Lu, Hailing; Disis, Mary L
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Identification and Validation of Th1-Selective Epitopes Derived from Proteins Overexpressed in Breast Cancer Stem Cells.

鉴定和验证源自乳腺癌干细胞中过表达蛋白质的 Th1 选择性表位

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13050525
Cecil Denise L, Herendeen Daniel, Slota Meredith, O'Meara Megan M, Dang Yushe, Corulli Lauren, Disis Mary L
发育与干细胞
细胞生物学
乳腺癌
发表日期：2025
文献求助 收藏

Efficacy and safety of endoscopic fenestration for treating giant middle cranial fossa arachnoid cysts in pediatrics

内镜开窗术治疗儿童巨大中颅窝蛛网膜囊肿的疗效和安全性

期刊:Frontiers in Pediatrics
影响因子:2
doi:10.3389/fped.2025.1518422
Guo, Huachao; Ma, Zhen; Lv, Qiang; Li, Tao; Dong, Liujian; Yu, Jinliang; Feng, Shubin; Wang, Yushe
发表日期：2025
文献求助 收藏

Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer

腹腔内注射地尼白介素（ONTAK）免疫疗法治疗复发难治性卵巢癌

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2024.09.019
Liao, John B; Jejurikar, Nikita S; Hitchcock-Bernhardt, Katie M; Gwin, William R; Reichow, Jessica L; Dang, Yushe; Childs, Jennifer S; Coveler, Andrew L; Swensen, Ron E; Goff, Barbara A; Disis, Mary L; Salazar, Lupe G
NTA
肿瘤
肿瘤免疫
卵巢癌
免疫/内分泌
发表日期：2024
文献求助 收藏

Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients With Advanced-Stage ERBB2-Positive Breast Cancer: A Phase 1 Nonrandomized Clinical Trial

编码ERBB2胞内结构域的质粒DNA疫苗在晚期ERBB2阳性乳腺癌患者中的安全性和疗效：一项1期非随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2022.5143
Disis, Mary L Nora; Guthrie, Katherine A; Liu, Ying; Coveler, Andrew L; Higgins, Doreen M; Childs, Jennifer S; Dang, Yushe; Salazar, Lupe G
ERBB2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer

针对 HER2 过表达乳腺癌难治性患者开展的 HER2 疫苗预处理自体 T 细胞输注 I/II 期临床试验

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-22-3578
Mary L Disis, Yushe Dang, Andrew L Coveler, Jennifer S Childs, Doreen M Higgins, Ying Liu, Jing Zhou, Sean Mackay, Lupe G Salazar
免疫
细胞生物学
乳腺癌
肿瘤细胞
发表日期：2023
文献求助 收藏

Discovery of Thieno[2,3- e]indazole Derivatives as Novel Oral Selective Estrogen Receptor Degraders with Highly Improved Antitumor Effect and Favorable Druggability

发现噻吩并[2,3- e]吲唑衍生物作为新型口服选择性雌激素受体降解剂，具有高度增强的抗肿瘤作用和良好的成药性

期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.2c00008
Zhengyu Lu, Yangzhi Cao, Dan Zhang, Xin Meng, Bin Guo, Deyu Kong, Yushe Yang
肿瘤
发表日期：2022
文献求助 收藏

An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options

多囊卵巢综合征最新进展：诊断、遗传病因和新兴治疗方案的最新研究进展综述

期刊:
影响因子:
doi:10.1177/17455057221117966
Islam, Hiya; Masud, Jaasia; Islam, Yushe Nazrul; Haque, Fahim Kabir Monjurul
多囊卵巢综合征
免疫/内分泌
发表日期：2022
文献求助 收藏

Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses

在晚期卵巢癌中，用编码胰岛素样生长因子结合蛋白-2 N 端的质粒 DNA 疫苗进行免疫接种可诱导高水平的 I 型免疫反应

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-1579
Cecil, Denise L; Liao, John B; Dang, Yushe; Coveler, Andrew L; Kask, Angela; Yang, Yi; Childs, Jennifer S; Higgins, Doreen M; Disis, Mary L
肿瘤
免疫/内分泌
肿瘤免疫
卵巢癌
发表日期：2021
文献求助 收藏

Giant Intraparenchymal Meningioma in a Female Child: Case Report and Literature Review

女性儿童巨大脑实质内脑膜瘤：病例报告及文献综述

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S294224
Guo, Huachao; Liang, Hao; Wang, Jiaguang; Wen, Shuo; Wang, Yong; Wang, Yushe; Ma, Zhen
神经科学
发表日期：2021
文献求助 收藏